Selena Gomez, her mother Mandy Teefey and Wondermind co-founder Daniella Pierson are facing a federal fraud lawsuit filed by investors in the mental-health media startup, accusing the trio of fabricating corporate partnerships and misrepresenting the company's finances to secure roughly $1.2 million in funding, according to NBC News.

The suit, filed Thursday in Delaware federal court by the investor entities Wondermind SRS 44 LLC and Bespoke Wondermind SPV I LLC, alleges the founders misrepresented Wondermind's infrastructure, leadership and business relationships — including partnerships with JPMorgan Chase and Fidelity that, the complaint says, never actually existed. Investors also say they were promised an app, advertising deals and celebrity cover-story placements that failed to materialize, and that they were kept largely in the dark about the company's deteriorating finances for roughly three years, per TechCrunch's reporting on the filing.

"The Partnerships Did Not Exist"

Wondermind, which Gomez co-founded with Teefey and Pierson in November 2021 to publish mental-health content and products, is also accused in the complaint of having Gomez sign a contract to serve as head of marketing that she then never fulfilled. "Gomez purposed to sign a contract obligating her to perform and then ignored it. The partnerships did not exist," the complaint states, according to NBC News.

"THE PARTNERSHIPS DID NOT EXIST"

The lawsuit further alleges that Pierson misappropriated company funds for personal expenses, including $60,000 in monthly rent, according to the reporting. The claims span securities fraud, common-law fraud, breach of contract, conversion and unjust enrichment — a wide-ranging legal attack that, if it proceeds, could force Gomez and her co-founders to answer detailed questions under oath about the company's inner workings.

Representatives for Gomez, Teefey, Pierson and Wondermind had not issued a public response to the allegations as of Friday, and the company has not commented on the specific claims in the filing. The case adds a serious legal complication to a brand built explicitly around wellness and transparency — and one that investors now say was neither.